Cargando…
Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death
Antibodies that target immune checkpoint proteins such as programmed cell death protein 1, programmed death ligand 1, and cytotoxic T-lymphocyte–associated antigen 4 in human cancers have achieved impressive clinical success; however, a significant proportion of patients fail to respond to these tre...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006662/ https://www.ncbi.nlm.nih.gov/pubmed/35283189 http://dx.doi.org/10.1016/j.jbc.2022.101821 |